Informe completo: Stereotactic ablative radiotherapy for the treatment of oligometastatic cancer: a clinical review as part of a health technology assessment v1.0
Objetivo: Stereotactic ablative radiotherapy for the treatment of oligometastatic cancer. This review is being regularly updated according to a living systematic review approach.
Autoría: Canadian Agency for Drugs and Technologies in Health (CADTH)
Idioma: inglés
Fuente: INAHTA
Año de publicación: 2021